Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts

被引:180
作者
Wright, LM
Maloney, W
Yu, XF
Kindle, L
Collin-Osdoby, P
Osdoby, P
机构
[1] Washington Univ, Dept Biol, St Louis, MO 63130 USA
[2] Washington Univ, Sch Med, Div Bone & Mineral Metab, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Orthoped, St Louis, MO 63110 USA
关键词
stromal cell-derived factor-1; osteoclasts; RANKL; chemotaxis; apoptosis;
D O I
10.1016/j.bone.2005.01.021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Osteoclasts (Oc) derive from hematopoietic precursors present in the circulation and bone marrow, and they differentiate into multinucleated bone-resorbing cells in response to the dual essential signals receptor activator of NF-kappa B ligand (RANKL) and macrophage-colony stimulating factor (M-CSF) primarily provided by bone marrow stromal cells (BMSC) and osteoblasts (Ob). However, little is known about signals that direct Oc precursors from the circulation into bone or control their migration within the marrow. Stromal cell-derived factor-1 (SDF-1 or CXCL12) is a chemokine highly expressed by bone endothelium, BMSC, and immature Ob that is essential for the normal homing, early development, and survival of various hematopoietic progenitor cells. We investigated whether SDF-1 and its unique chemokine receptor CXCR4 were involved in regulating human Oc precursor chemotaxis, development, function, or survival. CXCR4 was highly expressed by freshly isolated human monocyte (MN) populations, in vitro generated Oc and Oc-like cells, and mature Oc isolated from human femoral bones. SDF-1 markedly stimulated the chemotactic recruitment of circulating human MN capable of generating bone-resorptive Oc, leading to a 4-fold increase in Oc formation and greater bone pit resorption after their M-CSF + RANKL induced differentiation compared to spontaneously migrating cells. SDF-1 also directly promoted early (but not later) stages of Oc development via stimulating precursor cell numbers, multinucleated cell fusion, increased cell size, and tartrate-resistant acid phosphatase (TRAP) activity in a similar, but non-additive, fashion to M-CSF + RANKL. While SDF-1 did not cause full development of bone-resorbing Oc or stimulate the resorptive function of mature Oc directly, it also did not interfere with any actions promoted by M-CSF + RANKL. In mature human Oc, SDF-1 proved equally as effective as M-CSF + RANKL for preventing Oc apoptosis induced by cytokine withdrawal. In both cases, Oc survival was accompanied by analogous rises in the mRNA ratios for anti-apoptotic Bcl-x(L) and Bfl-1 relative to pro-apoptotic Bax, and by marked protein suppression of the critical pro-apoptotic signal Bim. These findings demonstrate for the first time that SDF-1 chemoattracts circulating human Oc precursors capable of developing into bone-resorptive Oc, and that it can stimulate MN cell fusion and TRAP activity, mimic M-CSF + RANKL in early osteoclastogenic effects, substitute for M-CSF + RANKL in maintaining the survival of mature human Oc, and suppress Oc expression of Bim protein. Thus, high levels of SDF-1 produced by bone endothelium, BMSC, and Ob may selectively target circulating Oc precursors into bone and stimulate their marrow migration into suitable perivascular stromal sites for their early development, RANKL differentiation, and survival. Consequently, SDF-1 may be a key factor linking bone vascular cells, BMSC, Ob, and Oc in the normal homeostatic regulation of bone development and remodeling. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:840 / 853
页数:14
相关论文
共 75 条
[1]   Tumor necrosis factor-α inhibits pre-osteoblast differentiation through its type-1 receptor [J].
Abbas, S ;
Zhang, YH ;
Clohisy, JC ;
Abu-Amer, Y .
CYTOKINE, 2003, 22 (1-2) :33-41
[2]   Fibroblast growth factor inhibits chondrocytic growth through induction of p21 and subsequent inactivation of cyclin E-Cdk2 [J].
Aikawa, T ;
Segre, GV ;
Lee, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (31) :29347-29352
[3]   The chemokine SDF-1 is a chemoattractant for human CD34(+) hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34(+) progenitors to peripheral blood [J].
Aiuti, A ;
Webb, IJ ;
Bleul, C ;
Springer, T ;
GutierrezRamos, JC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (01) :111-120
[4]   Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim [J].
Akiyama, T ;
Bouillet, P ;
Miyazaki, T ;
Kadono, Y ;
Chikuda, H ;
Chung, UG ;
Fukuda, A ;
Hikita, A ;
Seto, H ;
Okada, T ;
Inaba, T ;
Sanjay, A ;
Baron, R ;
Kawaguchi, H ;
Oda, H ;
Nakamura, K ;
Strasser, A ;
Tanaka, S .
EMBO JOURNAL, 2003, 22 (24) :6653-6664
[5]   Long-term hematopoietic stem cells require stromal cell-derived factor-1 for colonizing bone marrow during ontogeny [J].
Ara, T ;
Tokoyoda, K ;
Sugiyama, T ;
Egawa, T ;
Kawabata, K ;
Nagasawa, T .
IMMUNITY, 2003, 19 (02) :257-267
[6]   Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor κB (RANK) receptors [J].
Arai, F ;
Miyamoto, T ;
Ohneda, O ;
Inada, T ;
Sudo, T ;
Brasel, K ;
Miyata, T ;
Anderson, DM ;
Suda, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (12) :1741-1754
[7]   Chemokines in pathology and medicine [J].
Baggiolini, M .
JOURNAL OF INTERNAL MEDICINE, 2001, 250 (02) :91-104
[8]   Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease [J].
Bendre, MS ;
Montague, DC ;
Peery, T ;
Akel, NS ;
Gaddy, D ;
Suva, LJ .
BONE, 2003, 33 (01) :28-37
[9]  
Bouillet P, 2000, ANN NY ACAD SCI, V926, P83
[10]   Receptor activator of NF-κB and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis [J].
Collin-Osdoby, P ;
Rothe, L ;
Anderson, F ;
Nelson, M ;
Maloney, W ;
Osdoby, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (23) :20659-20672